Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

INTRODUCTION: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is known to be chemosensitive. In patients with TNBC, we sought to compare survival outcomes between patients receiving neoadjuvant chemotherapy, with and without complete pathologic response (pCR), and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Fisher, Carla S., Ma, Cynthia X., Gillanders, William E., Aft, Rebecca L., Eberlein, Timothy J., Gao, Feng, Margenthaler, Julie A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2011
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3892697/
https://ncbi.nlm.nih.gov/pubmed/21725686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-011-1877-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk